This location housed its emerging markets business unit that was previously based in Zurich, the Takeda Development Centre Asia and its vaccine business unit. In addition, the laboratory facilities was accelerated to meet tight deadlines.
Japanese drugmaker Takeda Pharmaceutical needed to consolidate its Singapore operations and thus engaged ID21 to design its regional headquarters in Biopolis.
The site fell under URA’s 60:40 rule, and ID21 helped the client to fulfil its design objectives effectively. We created an office that was both cosy, private and comfortable with Takeda's corporate branding infused. The laboratory was demanding as we created a layout for proper material flow, electrical, plumbing, sanitary and gas distribution.
Construction expertise included building an AHU above the ceiling. Through close monitoring on each step of the process, ID21 followed through and delivered on time to a delighted customer.